EULAV Asset Management’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.94M | Buy |
22,105
+5
| +0% | +$1.57K | 0.16% | 118 |
|
|
2025
Q1 | $6.73M | Hold |
22,100
| – | – | 0.17% | 121 |
|
|
2024
Q4 | $7.34M | Hold |
22,100
| – | – | 0.18% | 120 |
|
|
2024
Q3 | $7.38M | Hold |
22,100
| – | – | 0.18% | 118 |
|
|
2024
Q2 | $9.1M | Hold |
22,100
| – | – | 0.25% | 101 |
|
|
2024
Q1 | $8.93M | Hold |
22,100
| – | – | 0.25% | 99 |
|
|
2023
Q4 | $6.77M | Buy |
22,100
+6,200
| +39% | +$1.9M | 0.21% | 108 |
|
|
2023
Q3 | $3.85M | Hold |
15,900
| – | – | 0.14% | 131 |
|
|
2023
Q2 | $3.82M | Hold |
15,900
| – | – | 0.14% | 135 |
|
|
2023
Q1 | $2.99M | Hold |
15,900
| – | – | 0.12% | 146 |
|
|
2022
Q4 | $3.38M | Hold |
15,900
| – | – | 0.15% | 129 |
|
|
2022
Q3 | $2.5M | Hold |
15,900
| – | – | 0.11% | 155 |
|
|
2022
Q2 | $2.38M | Hold |
15,900
| – | – | 0.1% | 166 |
|
|
2022
Q1 | $2.6M | Hold |
15,900
| – | – | 0.08% | 179 |
|
|
2021
Q4 | $3.46M | Buy |
15,900
+1,500
| +10% | +$326K | 0.09% | 175 |
|
|
2021
Q3 | $2.73M | Buy |
14,400
+500
| +4% | +$94.7K | 0.07% | 179 |
|
|
2021
Q2 | $2.46M | Hold |
13,900
| – | – | 0.06% | 183 |
|
|
2021
Q1 | $2.28M | Hold |
13,900
| – | – | 0.06% | 200 |
|
|
2020
Q4 | $1.94M | Hold |
13,900
| – | – | 0.05% | 208 |
|
|
2020
Q3 | $1.55M | Hold |
13,900
| – | – | 0.05% | 212 |
|
|
2020
Q2 | $1.29M | Hold |
13,900
| – | – | 0.04% | 220 |
|
|
2020
Q1 | $1.02M | Hold |
13,900
| – | – | 0.04% | 220 |
|
|
2019
Q4 | $1.17M | Buy |
13,900
+7,300
| +111% | +$613K | 0.04% | 242 |
|
|
2019
Q3 | $555K | Buy |
+6,600
| New | +$555K | 0.02% | 285 |
|